Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2024-01-31 00:00:00 ET · period of report 2024-01-29 · accession 0001104659-24-008868 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-31 | 2024-01-29 | RCUS | GILEAD SCIENCES, INC. | 10% | P - Purchase | $21.00 | +15.24M | 30.06M | +103% | +$320.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-29 | P | A | 15,238,095 | $21.00 | 30,061,124 | D | — | — |